Microvascular alterations in patients with SARS-COV-2 severe pneumonia

© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/. To the Editor,

To the Editor, Multiple evidences suggest that pulmonary microcirculatory dysfunction may play a key role in the pathogenesis of SARS-COV-2 severe pneumonia.
SARS-COV-2 uses the angiotensin converting enzyme 2 (ACE2) as its receptor [1]. ACE2 normally functions as a negative regulator of the renin-angiotensin system (RAS) [1]. RAS dysregulation leads to increased vascular permeability, inflammation and pneumocyte apoptosis [1]. Pulmonary microvascular leakage may result in lung oedema and impaired lung function.
Severe Coronavirus disease 2019 (COVID-19) is frequently complicated by coagulopathy and markedly elevated D-dimer is associated with poor prognosis [2]. The formation of micro-thrombi in the lung vessels likely contributes to ventilation/perfusion mismatch and impairs gas exchange.
In this study, we reviewed data from mechanically ventilated patients with SARS-COV-2 severe pneumonia admitted to an intensive care unit (ICU) of Ancona (Italy) in March 2020, who underwent an evaluation of the sublingual microcirculation by means of incident dark field videomicroscopy (Cytocam, Braedius Medical, Amsterdam, NL). The protocol of this retrospective observational study was approved by the local Ethics Committee (Comitato Etico Regionale delle Marche).
The Cytocam is a third generation handheld videomicroscope that enables the non-invasive, real-time, in vivo visualization of the microcirculation [3]. This technique is routinely applied in our ICU to monitor microvascular perfusion. Three videos from different sublingual areas were recorded with adequate contrast and focus and without pressure artefacts. The videos were analysed offline with dedicated software (Automated Vascular Analysis 3.2, Microvision Medical, Amsterdam, NL) to obtain parameters of vessel density (total vessel density [TVD], perfused vessel density [PVD]) and blood flow quality (microvascular flow index [MFI], percentage of perfused vessels [PPV] and flow heterogeneity index [HI]), as described elsewhere [3].
Data are presented as mean (± standard deviation) or median [1st-3rd quartile], based on the distribution of the variable of interest. The Spearman's rho was calculated to evaluate correlations between variables with a significance level of 0.05 (IBM SPSS Statistics for Windows, Version 21.0. Armonk, NY: IBM Corp).
Among 29 patients with SARS-COV-2 severe pneumonia who were admitted to our ICU during the study period, 12 patients underwent microcirculatory evaluation. Patients' characteristics are reported in Table 1  This is the first study that evaluated microcirculatory blood flow in COVID-19 patients. Microvascular alterations are associated with mortality in critically ill patients [3]. In a general population of 97 critically ill patients, we previously reported a PVD of 19.3 ± 4.4 mm/mm 2 [3], which seems significantly higher in comparison with the value observed in this sample of COVID-19 patients. Varga et al. recently reported signs of endotheliitis in several organs in patients with SARS-COV-2 infection, suggesting systemic microvascular dysfunction that may account for tissue hypoperfusion, inflammation and a procoagulant state [4].
Sublingual microcirculatory blood flow was significantly compromised in patients with severe influenza A (H1N1) infection [5]. In acute respiratory distress syndrome, increased heterogeneity of sublingual microvascular perfusion was related to an increase in dead-space ventilation, suggesting a role of microcirculatory dysfunction in ventilation/perfusion mismatching [6].
Our report supports a link between coagulopathy and microvascular perfusion disturbances in patients with SARS-COV-2 severe pneumonia. Further studies are needed to demonstrate a cause-effect relationship, clarify the role of microcirculatory disturbances on lung function and indicate potential implications for therapy.